16 May 2016 in Journal of Clinical & Translational Endocrinology
To characterize and compare the beta-cell function and insulin resistance among Peruvian adolescents with type 2 diabetes (T2D) and their non-diabetic, overweight and lean peers. Cross-sectional study of 54 adolescents aged 10-19 years, distributed in three sex- and age-matched groups (n = 18): (i) adolescents with T2D; (ii) overweight adolescents without T2D; and (iii) lean adolescents without T2D, at the Diabetes, Obesity and Nutrition Research Center in Lima, Peru. Fasting glucose, insulin, C-peptide, and glycated hemoglobin were measured for all participants. In addition, a two-hour oral glucose tolerance test (OGTT, 1.75 mg of glucose/kg body weight) was performed, during which glucose and C-peptide were quantified. The homeostasis model assessment of insulin resistance (HOMA-IR) and beta-cell function (HOMA-B) were derived for all participants, and beta-cell function was further examined by the area under the curve (AUC) of C-peptide. The median HOMA-IR score was higher in adolescents with T2D compared to lean adolescents (6.1 vs. 2.1; p = 0.002), but was not different from that of overweight adolescents (6.1 vs. 4.0; p = 0.322). The median HOMA-B was higher in overweight adolescents than in lean adolescents (256.9 vs. 134.2; p = 0.015), and adolescents with T2D (256.9 vs. 119.8; p = 0.011). The mean AUC of glucose in adolescents with T2D was 1.8-fold higher than that of overweight adolescents, and 1.9-fold higher than that of lean adolescents (p < 0.001). Although the median AUC of C-peptide in adolescents with T2D was lower than that of overweight and lean adolescents, this difference was not statistically significant (230.7 vs. 336.6 vs. 267.3 nmol/l120 min, respectively; p = 0.215). Among Peruvian adolescents with T2D, insulin resistance is the most prominent characteristic, rather than beta-cell dysfunction.
30 September 2026 in Revista de la Facultad de Medicina Humana
Introduction: Some complete blood count–derived indices could be useful for assessing hemoglobinization abnormalities. Objective: To evaluate the diagnostic performance of the microcytic anemia factor (MAF) and low hemoglobin density (LHD%) for identifying hemoglobinization abnormalities consistent with iron-restricted erythropoiesis, using Ret-He <28 pg as the functional reference standard, in blood donor candidates. Methods: A retrospective cross-sectional diagnostic accuracy study was conducted, including 227 blood donor candidates evaluated at the Hemotherapy and Blood Bank Service of Hospital Cayetano Heredia, Lima, Peru. Participants were classified according to Ret-He <28 pg and Ret-He ≥28 pg. MAF and LHD% were calculated from complete blood count parameters. Diagnostic performance was evaluated using receiver operating characteristic (ROC) curve analysis, and the area under the curve (AUC), sensitivity, and specificity were estimated. Results: Overall, 17.2% (39/227) of blood donor candidates had Ret-He 5.60, a sensitivity of 92.3%, and a specificity of 84.6%. No statistically significant difference was observed between the two ROC curves. Conclusions: MAF and LHD% showed good diagnostic performance for identifying low reticulocyte hemoglobinization in blood donor candidates. LHD% showed a more favorable screening profile because of its higher sensitivity, whereas MAF showed higher specificity.
8 May 2023 in ACTA MEDICA PERUANA
Objetivo: Determinar la correlación entre la glucosa salival y marcadores de disfunción de célula beta en pacientes con Diabetes Mellitus tipo 2 (DM2). Materiales y métodos: Estudio transversal llevado a cabo en el Centro de Investigación en Diabetes, Obesidad y Nutrición (CIDON) en Lima, Perú durante el año 2021. Se categorizó en buen control metabólico (HbA1c<7%) y mal control metabólico (HbA1c≥7%). Se midió la glucosa basal, HbA1c y el péptido C en sangre. La glucosa salival se midió con el método glucosa-oxidasa. La correlación de Spearman fue usada para determinar la asociación entre la glucosa salival y los marcadores de disfunción de célula beta. Resultados: Participaron un total de 142 personas con DM2. La concentración de glucosa salival fue significativamente más elevada en DM2 con mal control metabólico (p<0.01). Se observó una correlación positiva débil significativa entre la glucosa salival y la glucosa basal (r=0.23, p=0.04) y HbA1c (r=0.26, p=0.02) en DM2 con mal control metabólico y una correlación negativa insignificante (r=-0.08; p=0.47) con el péptido C. Conclusiones: La glucosa salival presenta una asociación significativa y positiva con la glucosa en sangre y la HbA1c, pero no con el péptido C en personas con DM2 con mal control metabólico. Sin embargo, hay muchos factores que deben ser considerados y analizados más a fondo para determinar su posible uso.
22 October 2023 in ACTA MEDICA PERUANA
Objective: to determine the relationship between Ret-He with different categories according to hemoglobin concentration in candidates for blood donation. Methods: A cross-sectional study was carried out based on the review of 227 medical records of candidates to donate blood during the month of December 2021 in the Blood Bank and Hemotherapy Service of the Cayetano Heredia Hospital. They were categorized into 3 groups according to hemoglobin levels: Group 1: ≥12.5 g/ dl (females) - ≥13.5 g/dl (males). Group 2: 12 g/dl ≥ females <12.5 g/dl and 13 g/dl ≥ males<13.5 g/dl. Group 3: <12 g/dl (females) - <13 g/dl (males). Hematocrit, hemoglobin, VCM, HCM, CHCM and Ret-He data were collected. For the bivariate analysis, analysis of variance (ANOVA) was used and a significance level of 5% was considered. Results: The median Ret-He was higher in group 1 than in group 2 (33.5 vs. 32.5; p=0.002) and in group 3 (33.5 vs. 27.8; p<0.001). A statistically significant relationship was found between the groups studied and Ret-He (p<0.001), in addition to a moderate-strong positive correlation between Ret-He and erythrocyte indices. Conclusions: An association was found between groups based on hemoglobin categories and Ret-He in blood donation candidates.
13 May 2024 in Anales de la Facultad de Medicina
Introducción : Los analizadores hematológicos Beckman-Coulter han utilizado el Factor de anémica microcítica (Maf®) como herramienta de detección sencilla y económica para la detección temprana de deficiencia de hierro ( DH). Objetivo: determinar la relación entre deficiencia de hierro y el Maf® y evaluar el rendimiento diagnóstico en la detección de deficiencia de hierro en postulantes diferidos a donar sangre. Materiales y Métodos: Estudio transversal. Se revisó 159 historias clínicas de postulantes a donar sangre diferidos por tener valores de hemoglobina menores de 12.5 gr/dl (mujeres) y menores de 13.5 gr/dl (varones) que acudieron al Servicio de Hemoterapia y Banco de Sangre del Hospital Nacional Cayetano Heredia en Lima-Perú. DH fue categorizada con valores de ferritina ≤ 30 ng/ml. Maf® fue calculado con datos obtenidos del hemograma mediante la formula Maf® = ((Hemoglobina x Volumen Corpuscular Medio) /100)). Se utilizó la Curva de la característica operativa del receptor (ROC) con el área bajo la curva (AUC) para predecir DH. Resultados: el 45.5% de los participantes del sexo femenino presentó deficiencia de hierro. Se encontró una relación significativa entre DH y Maf® (p<0.001). El análisis ROC para Maf® y el diagnóstico de DH mostró un AUC de 0.9174 con un punto de corte de 8.97 (sensibilidad 90% y especificad del 81.16%). Conclusiones: Se encontró una asociación significativa entre deficiencia de hierro y el Maf®. Además, este parámetro tiene una buena performance para discriminar deficiencia de hierro en postulantes diferidos a donar sangre.